Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 45 Prostatic Neoplasms 41 Brain Neoplasms 27 Lung Neoplasms 19 Glioblastoma 17 Glioma 16 Neoplasms 13 Neoplasm Metastasis 13 Carcinoma, Non-Small-Cell Lung 13 Head and Neck Neoplasms 10 Pancreatic Neoplasms 8 Central Nervous System Neoplasms 8 Uterine Cervical Neoplasms 7 Lymphoma 7 Carcinoma, Hepatocellular 7 Rectal Neoplasms 6 Oligodendroglioma 6 Gliosarcoma 6 Carcinoma, Squamous Cell 6 Astrocytoma 6 Squamous Cell Carcinoma of Head and Neck 5 Esophageal Neoplasms 5 Ependymoma 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Carcinoma, Intraductal, Noninfiltrating 5 Sarcoma 4 Meningioma 4 Colonic Neoplasms 4 Breast Neoplasms, Male 4

Interventions

Blood Specimen Collection 3 Surveys and Questionnaires 2 Practice Guidelines as Topic 1 Methods 1 Magnetic Resonance Spectroscopy 1 Lasers, Semiconductor 1 Hyperthermia, Induced 1 Hematologic Tests 1 Health Promotion 1 Focus Groups 1 Exercise 1 Educational Status 1 Cytidine Diphosphate Choline 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Uveal Melanoma × Magnetic Resonance Spectroscopy × Clear all

NCT04424719 2025-09-03

SALOME

Institut Curie

Phase NA Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡